Tag: Taliglucerase alfa

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Taliglucerase alfa

Protalix Biotherapeutics (NYSEAMERICAN:PLX) Given a $5.00 Price Target by HC Wainwright ...

Added to Collection on: 2017-12-07 23:22:30

Tags for this article:

Protalix BioTherapeutics
Taliglucerase alfa
Protalix BioTherapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Protalix Biotherapeutics Inc (PLX) Shares Sold by Renaissance Technologies LLC

Added to Collection on: 2018-05-03 22:33:31

Tags for this article:

Protalix BioTherapeutics
Taliglucerase alfa
Protalix BioTherapeutics Inc
Renaissance Technologies LLC
PLX
Companies

Click the tags to see associated articles and topics

View Article Details
Protalix Biotherapeutics Inc (PLX) Sees Large Decline in Short Interest

Added to Collection on: 2018-08-26 15:07:30

Tags for this article:

Protalix BioTherapeutics
Taliglucerase alfa
Protalix BioTherapeutics Inc
PLX
Companies

Click the tags to see associated articles and topics

View Article Details
Renaissance Technologies LLC Acquires 305200 Shares of Protalix Biotherapeutics Inc (PLX)

Added to Collection on: 2018-11-24 07:37:30

Tags for this article:

Protalix BioTherapeutics
Taliglucerase alfa
Protalix BioTherapeutics Inc
Renaissance Technologies LLC

Click the tags to see associated articles and topics

View Article Details
Protalix Biotherapeutics (PLX) Issues Earnings Results

Added to Collection on: 2019-03-18 23:56:15

Tags for this article:

Protalix BioTherapeutics
Taliglucerase alfa
Protalix BioTherapeutics Inc
Virtu Financial
Companies

Click the tags to see associated articles and topics

View Article Details
Protalix Biotherapeutics Stock Scheduled to Reverse Split on Friday, December 20th ...

Added to Collection on: 2020-01-01 14:33:45

Tags for this article:

Protalix BioTherapeutics
Companies
PLX
Taliglucerase alfa
Wedbush Securities
Protalix BioTherapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Protalix BioTherapeutics Announces Submission of Type A Meeting Request to the FDA

Added to Collection on: 2021-08-02 10:41:15

Tags for this article:

Life Sciences
Biology
Biotechnology
Protalix BioTherapeutics
Taliglucerase alfa
PLX
Fabry disease
Biopharmaceutical
Recombinant DNA
Food and Drug Administration
PEGylation
Pharming
u.s. food and drug administration
Protalix BioTherapeutics Inc
PRX-102

Click the tags to see associated articles and topics

View Article Details
Protalix BioTherapeutics to Release Second Quarter 2021 Financial Results and Provide a ...

Added to Collection on: 2021-08-09 11:15:00

Tags for this article:

Life Sciences
Biotechnology
Biology
Protalix BioTherapeutics
Molecular biology
Taliglucerase alfa
Recombinant proteins
PLX
Recombinant DNA
Biopharmaceutical
Dornase alfa
Chiesi Farmaceutici
Protalix BioTherapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Protalix Biotherapeutics Hosting Key Opinion Leader Webinar on Fabry Disease and PRX-102

Added to Collection on: 2022-12-04 21:06:16

Tags for this article:

Branches of biology
Life Sciences
Inborn errors of metabolism
Biotechnology
Rare diseases
Molecular biology
Lipid storage disorders
Protalix BioTherapeutics
Lysosomal storage diseases
Fabry disease
Taliglucerase alfa
Alpha-galactosidase
Protalix BioTherapeutics Inc

Click the tags to see associated articles and topics

View Article Details